JP Morgan Private Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $68.1M | Sell |
155,814
-26,851
| -15% | -$13.4M | 0.19% | 120 |
|
|
2023
Q2 | $91.7M | Sell |
182,665
-16,325
| -8% | -$7.82M | 0.48% | 47 |
|
|
2023
Q1 | $99.5M | Buy |
198,990
+9,217
| +5% | +$4.41M | 0.21% | 108 |
|
|
2022
Q4 | $77.4M | Sell |
189,773
-19,820
| -9% | -$7.69M | 0.17% | 128 |
|
|
2022
Q3 | $68.3M | Sell |
209,593
-1,563
| -0.7% | -$574K | 0.18% | 129 |
|
|
2022
Q2 | $74.1M | Sell |
211,156
-12,775
| -6% | -$5.21M | 0.19% | 123 |
|
|
2022
Q1 | $123M | Buy |
223,931
+6,245
| +3% | +$3.29M | 0.27% | 90 |
|
|
2021
Q4 | $143M | Buy |
217,686
+106
| +0% | +$66.5K | 0.31% | 80 |
|
|
2021
Q3 | $135M | Buy |
217,580
+5,991
| +3% | +$4.03M | 0.33% | 71 |
|
|
2021
Q2 | $134M | Buy |
211,589
+20,702
| +11% | +$11.4M | 0.35% | 70 |
|
|
2021
Q1 | $93.4M | Sell |
190,887
-31,214
| -14% | -$15.6M | 0.3% | 76 |
|
|
2020
Q4 | $111M | Sell |
222,101
-4,686
| -2% | -$2.1M | 0.36% | 68 |
|
|
2020
Q3 | $89.2M | Buy |
226,787
+6,921
| +3% | +$2.56M | 0.35% | 69 |
|
|
2020
Q2 | $72.6M | Buy |
219,866
+4,171
| +2% | +$1.21M | 0.33% | 79 |
|
|
2020
Q1 | $52.3M | Sell |
215,695
-1,769
| -0.8% | -$462K | 0.3% | 89 |
|
|
2019
Q4 | $56.8M | Buy |
217,464
+4,224
| +2% | +$1.11M | 0.26% | 103 |
|
|
2019
Q3 | $58M | Buy |
213,240
+4,480
| +2% | +$1.25M | 0.3% | 84 |
|
|
2019
Q2 | $57.5M | Sell |
208,760
-744
| -0.4% | -$183K | 0.31% | 81 |
|
|
2019
Q1 | $46.8M | Sell |
209,504
-4,857
| -2% | -$1M | 0.24% | 102 |
|
|
2018
Q4 | $39.9M | Buy |
214,361
+845
| +0.4% | +$173K | 0.24% | 98 |
|
|
2018
Q3 | $53.3M | Sell |
213,516
-16,003
| -7% | -$3.88M | 0.26% | 91 |
|
|
2018
Q2 | $50M | Sell |
229,519
-7,959
| -3% | -$1.64M | 0.28% | 83 |
|
|
2018
Q1 | $45.5M | Sell |
237,478
-1,854
| -0.8% | -$342K | 0.31% | 77 |
|
|
2017
Q4 | $37.4M | Sell |
239,332
-15,287
| -6% | -$2.41M | 0.25% | 103 |
|
|
2017
Q3 | $39.6M | Sell |
254,619
-13,908
| -5% | -$2.2M | 0.29% | 91 |
|
|
2017
Q2 | $43.3M | Sell |
268,527
-6,286
| -2% | -$1.02M | 0.33% | 85 |
|
|
2017
Q1 | $42.5M | Sell |
274,813
-24,508
| -8% | -$3.38M | 0.33% | 81 |
|
|
2016
Q4 | $35.1M | Sell |
299,321
-12,275
| -4% | -$1.4M | 0.31% | 84 |
|
|
2016
Q3 | $35.1M | Buy |
311,596
+1,549
| +0.5% | +$163K | 0.33% | 83 |
|
|
2016
Q2 | $28.8M | Sell |
310,047
-10,803
| -3% | -$928K | 0.28% | 95 |
|
|
2016
Q1 | $25.1M | Buy |
320,850
+8,577
| +3% | +$618K | 0.24% | 103 |
|
|
2015
Q4 | $22.8M | Sell |
312,273
-3,631
| -1% | -$259K | 0.23% | 112 |
|
|
2015
Q3 | $23.5M | Buy |
315,904
+2,995
| +1% | +$215K | 0.29% | 97 |
|
|
2015
Q2 | $20.1M | Buy |
312,909
+3,933
| +1% | +$272K | 0.23% | 116 |
|
|
2015
Q1 | $23.9M | Buy |
308,976
+1,966
| +0.6% | +$153K | 0.27% | 98 |
|
|
2014
Q4 | $22.8M | Buy |
307,010
+3,768
| +1% | +$264K | 0.27% | 99 |
|
|
2014
Q3 | $17.9M | Sell |
303,242
-1,464
| -0.5% | -$92.6K | 0.23% | 119 |
|
|
2014
Q2 | $20.4M | Sell |
304,706
-7,562
| -2% | -$481K | 0.34% | 85 |
|
|
2014
Q1 | $19M | Buy |
312,268
+3,204
| +1% | +$191K | 0.35% | 86 |
|
|
2013
Q4 | $16.4M | Sell |
309,064
-7,800
| -2% | -$411K | 0.33% | 90 |
|
|
2013
Q3 | $15.8M | Sell |
316,864
-27,682
| -8% | -$1.33M | 0.36% | 87 |
|
|
2013
Q2 | $15.5M | Buy |
+344,546
| New | +$15.1M | 0.38% | 83 |
|
Other funds holding IDXX
JP Morgan Private Wealth Advisors's IDXX Position: Q3 2023 in Review
JP Morgan Private Wealth Advisors reduced its Idexx Laboratories (IDXX) stake by 15% in Q3 2023, selling an estimated $13.4M and leaving 155,814 shares worth $68.1M. The position accounts for 0.19% of the portfolio, ranked #120.
JP Morgan Private Wealth Advisors first reported a position in IDXX in Q2 2013 and has held it in 42 quarters since. The position peaked at $143M in Q4 2021. 1,060 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.
- JP Morgan Private Wealth Advisors held 155,814 shares of Idexx Laboratories worth $68.1M as of Q3 2023.
- JP Morgan Private Wealth Advisors sold 26,851 Idexx Laboratories shares in Q3 2023, an estimated $13.4M.
- Idexx Laboratories made up 0.19% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #120 holding.
- JP Morgan Private Wealth Advisors first reported a position in Idexx Laboratories in Q2 2013 and has held it in 42 quarters since.
- JP Morgan Private Wealth Advisors's Idexx Laboratories position peaked at $143M in Q4 2021.
- 1,060 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.
Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.